Elevate Credit Releases Potential Pricing for IPO

By Chris Lange Updated Jan 13, 3:12PM EST · Published Jan 11, 11:10AM EST

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Elevate Credit Releases Potential Pricing for IPO — © Thinkstock

Elevate Credit has registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company anticipates that it will price its 3.6 million shares in the range of $20 to $22 per share. At the maximum price, the offering is valued up to $79.2 million. The company intends to list on the New York Stock Exchange under the symbol ELVT.

The underwriters for the offering are UBS Investment Bank, Jefferies, Stifel, William Blair and BB&T Capital Markets.

The company offers technology-driven online credit solutions to non-prime consumers. This is for consumers with credit scores of less than 700 and who are not well-served by either banks or legacy non-prime lenders.

In the filing, the company said:

We currently offer online installment loans and lines of credit in the United States, or the “US,” and the United Kingdom, or the “UK.” Our products, Rise, Elastic and Sunny, reflect our mission of “Good Today, Better Tomorrow” and provide customers with access to competitively priced credit and services while helping them build a brighter financial future with credit building and financial wellness features.

[nativounit]
Elevate Credit’s generation of products includes Rise, Elastic and Sunny. They have provided approximately $1.2 billion in credit to approximately 450,000 customers and generated strong revenue growth as follows (verbatim from filing):

Our revenues for the year ended December 31, 2014 grew 280% to $274 million from $72 million for the year ended December 31, 2013 and revenues for the nine months ended September 30, 2015 grew 67% compared to the nine months ended September 30, 2014. Our operating losses for the years ended December 31, 2014 and 2013 were $61 million and $52 million, respectively and were $4 million and $51 million for the nine months ended September 30, 2015 and 2014, respectively.

Rise is offered in 15 states for installment payments for loans of $500 to $5,000 for four to 26 months. The Sunny product is offered in the United Kingdom, with loans of 100 to 2,500 pounds for six to 14 months. The Elastic product is a line of credit available in 40 states for amounts of $500 to $3,500 for up to 10 months.

The company intends to use the proceeds from this offering to repay a portion of its debt, as well as for working capital and general corporate purposes.

About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.